Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001387131-22-001901
Filing Date
2022-02-14
Accepted
2022-02-14 16:15:45
Documents
2
Group Members
BONDERMAN FAMILY LIMITED PARTNERSHIPLEONARD A. POTTERWILDCAT - LIQUID ALPHA, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDED ACQUISITION OF BENEFICIAL OWNERSHIP urgn-sc13ga_123121.htm SC 13G/A 75127
2 AGREEMENT OF JOINT FILING ex1.htm EX-1 5976
  Complete submission text file 0001387131-22-001901.txt   82709
Mailing Address 888 SEVENTH AVENUE 37TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 37TH FLOOR NEW YORK NY 10106 212-468-5100
Wildcat Capital Management, LLC (Filed by) CIK: 0001582384 (see all company filings)

EIN.: 453715536 | State of Incorp.: DE | Fiscal Year End: 1213
Type: SC 13G/A

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89992 | Film No.: 22632167
SIC: 2834 Pharmaceutical Preparations